Prevention of invasive Aspergillosis in immunocompromised cancer patients: What options?;Prävention invasiver Aspergillosen bei hochgradig immunsupprimierten onkologischen Patienten

Krankenhaushygiene und Infektionsverhutung

Volumn 26, Issue 4, 2004, Pages 157-163

  Simon, Arne ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

HEPA filtration; Invasive Aspergillosis; Prevention

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ITRACONAZOLE; VINCRISTINE; VORICONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CONIDIUM; ENVIRONMENTAL EXPOSURE; FILTRATION; HEALTH CARE COST; HEALTH CARE FACILITY; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; NEPHROTOXICITY; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; REVIEW; WATER CONTAMINATION;

EID: 4444318431     PISSN: 07203373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Abbasi S, Shenep JL, Hughes WT, Flynn PM: Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis 29: 1210-1219 (1999)
2. Alberti C, Bouakline A, Ribaud P, Lacroix C, Rousselot P, Leblanc T, Derouin F; Aspergillus Study Group: Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect 48: 198-206 (2001)
3. Anderson K, Morris G, Kennedy H, Croall J, Michie J, Richardson MD, Gibson B: Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 51: 256-261 (1996)
4. Anaissie EJ, Costa SF: Nosocomial aspergillosis in waterborne. Clin Infect Dis 33: 1546-1548 (2001)
5. Anaissie EJ, Stratton SL, Dignani MC, Summerbell RC, Rex JH, Monson TP, Spencer T, Kasai M, Francesconi A, Walsh TJ: Pathogenic aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 34: 780-778 (2002)
6. Anaissie EJ, Stratton SL, Dignani MC, Lee CK, Mahfouz TH, Rex JH, Summerbell RC, Walsh TJ: Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis 35: E86-88 (2002)
7. Anaissie EJ, Stratton SL, Dignani MC, Lee CK, Summerbell RC, Rex JH, Monson TP, Walsh TJ: Pathogenic molds (including aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. Blood 101: 2542-2546 (2003)
8. Anonymus: Construction-related nosocomial infections in patients in health care facilities. Decreasing the risk of Aspergillus, Legionella and other infections. Can Commun Dis Rep 27 Suppl 2: 1-42 (2001)
9. Anonymus: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC): Guidelines for Environmental Infection Control in Health-Care Facilities June 6, 2003/Vol 52/ No. RR-10 (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5210a1.htm)
10. Anonymus: Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation: Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients. MMWR October 20, 2000/49(RR10): 1-128
11. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34: 7-14 (2002)
12. Baddley JW, Stroud TP, Salzman D, Pappas PG.: Invasive mold infections in allogenic bone marrow transplant recipients. Clin Infect Dis 32: 1319-1324 (2001)
13. Baddley JW, Pappas PG, Smith AC, Moser SA: Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41: 5525-5529 (2003)
14. Barnes RA, Rogers TR: Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. Hosp Infect 14: 89-94 (1989)
15. Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Dasbach EJ, Platt R: Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 32: 686-693 (2001)
16. Böhme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, Heussel G, Heussel CP, Junghanss C, Kern WK, Kubin T, Maschmeyer G, Sezer O, Silling G, Sudhoff T, Szelenyi Dagger H, Ullmann AJ; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO): Treatment of fungal infections in hematology and oncology - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 Suppl 2: S133-140 (2003)
17. Bouakline A, Lacroix C, Roux N, Gangneux JP, Derouin F: Fungal contamination of food in hematology units. J Clin Microbiol 38: 4272-4273 (2000)
18. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, Ioannou S: Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 94: 3230-3246 (2002)
19. Burke JP: Patient safety: infection control - a problem for patient safety. N Engl J Med 348: 651-656 (2003)
20. Burwen DR, Lasker BA, Rao N, Durry E, Padhye AA, Jarvis WR: Invasive aspergillosis outbreak on a hematology-oncology ward. Infect Control Hosp Epidemiol 22: 45-48 (2001)
21. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, CDC, Healthcare Infection Control Practices Advisory Committee: Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004 Mar 26; 53 (RR-3): 1-36
22. Cooper EE, O'Reilly MA, Guest DI, Dharmage SC: Influence of building construction work on Aspergillus infection in a hospital setting. Infect Control Hosp Epidemiol 24: 472-476 (2003)
23. Cornet M, Levy V, Fleury L, Lortholary J, Barquins S, Coureul MH, Deliere E, Zittoun R, Brucker G, Bouvet A: Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 20: 508-513 (1999)
24. Denning DW, Stevens DA: Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 12: 1147-1201 (1990)
25. Denning DW: Invasive Aspergillosis (State of the Art Article). Clin Infect Dis 26: 781-805 (1998)
26. Eccles NK, Scott GM: Aspergillus in pepper. Lancet 339: 618 (1992)
27. Engelhart S, Hanfland J, Glasmacher A, Krizek L, Schmidt-Wolf IG, Exner M: Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions. J Hosp Infect 54: 300-304 (2003)
28. Fenelon LE: Protective isolation: who needs it? J Hosp Infect 30 Suppl: 218-222 (1995)
29. Gangneux JP, Bretagne S, Cordonnier C, Datry A, Derouin F, Grillot R, Kauffmann-Lacroix C, Lebeau B, Morin O, Nicolle MC, Piens MA, Poirot JL: Prevention of nosocomial fungal infection: the French approach. Clin Infect Dis 35: 343-346 (2002)
30. Glasmacher A, Prentice A, Gorschluter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG: Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. J Clin Oncol 21: 4615-4626 (2003)
31. Grigull L, Beier R, Schrauder A, Kirschner P, Loening L, Jack T, Welte K, Sykora KW, Schrappe M: Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses 46: 441-446 (2003)
32. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K: Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33: 23-32 (1996)
33. Groll AH, Kurz M, Schneider W, Witt V, Schmidt H, Schneider M, Schwabe D: Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 42: 431-442 (1999)
34. Groll AH, Walsh TJ: Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. Expert Opin Investig Drugs 10: 1545-1558 (2001)
35. Groll AH, Ritter J, Muller FM: Prevention of fungal infections in children and adolescents with cancer Klin Padiatr 213 Suppl 1: A50-68 (2001)
36. Hahn T, Cummings KM, Michalek AM, Lipman BJ, Segal BH, McCarthy PL Jr: Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol 23: 525-531 (2002)
37. Hajjeh RA, Warnock DW: Counterpoint: Invasive aspergillosis and the environment: rethinking our approach to prevention. Clin Infect Dis 33: 1549-1552 (2001)
38. Herbrecht R, Natarajan-Ame S, Nivoix Y, Letscher-Bru V: The lipid formulations of amphotericin B. Expert Opin Pharmacother 4: 1277-1287 (2003)
39. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408-415 (2002)
40. Herron MD, Vanderhooft SL, Byington C, King JD: Aspergillosis in a 24-week new-born: a case report. J Perinatol 23: 256-259 (2003)
41. Humphreys H.: Positive-pressure isolation and be prevention of invasive aspergillosis. What is the evidence? J Hosp Infect 56: 93-100 (2004)
42. Iwen PC, Reed EC, Armitage JO, Bierman PJ, Kessinger A, Vose JM, Arneson MA, Winfield BA, Woods GL: Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 14: 131-139 (1993)
43. Kamaluddin M, McNally P, Breatnach F, O'Marcaigh A, Webb D, O'Dell E, Scanlon P, Butler K, O'Meara A: Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. Acta Paediatr 90: 1204-1207 (2001)
44. Karthaus M (Hrsg): Pilzinfektionen bei Krebspatienten. Aktuelle Aspekte der Diagnostik und Therapie invasiver Mykosen. 3. aktual. erw. Aufl., Blackwell-Wissenschaftsverlag, Berlin 2003
45. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI): Anforderungen für Hygiene bei der Reinigung und Desinfektion von Flächen. Bundesgesundheitsbl Gesundheitsforsch gesudnheitsschutz 2004; 47: 51-61 (im Internet unter: http://www.rki.de/GESUND/HYGIENE/FLAECHE.PDF)
46. Kontoyiannis DP, Bodey GP: Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 21: 161-172 (2002)
47. Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II: Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 98: 292-299 (2003)
48. Leenders AC, Daenen S, Jansen RL, Hop WC, Lowenberg B, Wijermans PW, Cornelissen J, Herbrecht R, van der Lelie H, Hoogsteden HC, Verbrugh HA, de Marie S: Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol 103: 205-212 (1998)
49. Lehrnbecher T, Groll AH, Chanock SJ: Treatment of fungal infections in neutropenic children. Curr Opin Pediatr 11: 47-55 (1999)
50. Lin SJ, Schranz J, Teutsch SM: Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32: 358-366 (2001)
51. Loo VG, Bertrand C, Dixon C, Vitye D, DeSalis B, McLean AP, Brox A, Robson HG: Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 17: 360-364 (1996)
52. Loudon KW, Coke AP, Burnie JP, Shaw AJ, Oppenheim BA, Morris CQ: Kitchens as a source of Aspergillus niger infection. J Hosp Infect 32: 191-198 (1996)
53. Manuel RJ, Kibbler CC: The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 39: 95-109 (1998)
54. Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO): Diagnosis and anti-microbial therapy of pulmonary infiltrates in febrile neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 Suppl 2: S118-126 (2003)
55. Mahieu LM, De Dooy JJ, Van Laer FA, Jansens H, Ieven MM: A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit. J Hosp Infect 45: 191-197 (2000)
56. Matt P, Bernet F, Habicht J, Gambazzi F, Passweg J, Gratwohl A, Tamm M, Zerkowski HR: Short- and long-term outcome after lung resection for invasive pulmonary aspergillosis. Thorac Cardiovasc Surg 51: 221-225 (2003)
57. Neville K, Renberger J, Dreyer ZA: Pneumonia in the immunocompromised pediatric cancer patient. Seminars in Respir Infect 17: 21-32 (2002)
58. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M: Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97: 1604-1610 (2001)
59. Mahoney DH Jr, Steuber CP, Starling KA, Barrett FF, Goldberg J, Fernbach DJ: An outbreak of aspergillosis in children with acute leukemia. J Pediatr 95: 70-72 (1979)
60. Marr KA, Carter RA, Boeckh M, Martin P, Corey L: Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100: 4358-4366 (2002)
61. Marr KA, Carter RA, Crippa F, Wald A, Corey L: Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 909-917 (2002)
62. Masterton RG, Mifsud AJ, Rao GG; Hospital Isolation Precautions Working Group: Review of hospital isolation and infection control precautions. J Hosp Infect 54: 171-173 (2003) U.K.-Isolation Guidelines: http://www.amm.co.uk/documents/HIPFIN.DOC
63. McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger LA, Walesby RK, Hoffbrand AV, Prentice HG: Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 17: 397-404 (1993)
64. Müller FM, Trusen A, Weig M: Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. Eur J Pediatr 161: 563-574 (2002)
65. Munoz P, Burillo A, Bouza E: Environmental surveillance and other control measures in the prevention of nosocomial fungal infections. Clin Microbiol Infect 7 Suppl 2: 38-45 (2001)
66. Oren I, Haddad N, Finkelstein R, Rowe JM: Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 66: 257-262 (2001)
67. Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH: Amphotericin B: time for a new "gold standard". Clin Infect Dis 37: 415-425 (2003)
68. Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM: Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 21: 1231-1238 (1998)
69. Pegues CF, Daar ES, Murthy AR: The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital. Infect Control Hosp Epidemiol 22: 370-374 (2001)
70. Pegues DA, Lasker BA, McNeil MM, Hamm PM, Lundal JL, Kubak BM: Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin Infect Dis 34: 412-416 (2002)
71. Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, Kantarjian H, Bodey GP: Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 23: 41-43 (2002)
72. Reichenberger F, Habicht JM, Gratwohl A, Tamm M: Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 19: 743-755 (2002)
73. Risi GF, Tomascak V: Prevention of infection in the immunocompromised host. Am J Infect Control 26: 594-604 (1998)
74. Schwartz S, Behre G, Heinemann V, Wandt H, Schilling E, Arning M, Trittin A, Kern WV, Boenisch O, Bosse D, Lenz K, Ludwig WD, Hiddemann W, Siegert W, Beyer J: Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood 93: 3654-3661 (1999)
75. Sepkowitz KA, Farr BM: Three, if by air. Infect Control Hosp Epidemiol 24: 470-471 (2003)
76. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, Thomas RG, Samsa GP: Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 83: 709-718 (1987)
77. Singh N, Husain S: Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 22: 258-266 (2003)
78. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH: Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 21: 592-596 (2000)
79. Simon A, Fleischhack G: Nicht-medikamentöse Prophylaxe von Infektionen in der pädiatrischen Hämatologie und Onkologie. Klin Pädiatr 213 Suppl 1: A9-A21 (2001)
80. Simon A, Wiszniewsky G, Bode U: Surveillance nosokomialer Infektionen und FUO-Episoden in der pädiatrischen Onkologie mit dem Onkopäd NKI® Modul. Krh-Hyg + Infverh 25: 213-218 (2003)
81. Streifel AJ: In with the good air. Infect Control Hosp Epidemiol 23: 488-490 (2002)
82. Talbot GH, Huang A, Provencher M: Invasive aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis 13: 219-232 (1991)
83. Thio CL, Smith D. Merz WG, Streifel AJ, Bova G, Gay L, Miller CB, Perl TM: Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 21: 18-23 (2000)
84. Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DP: Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 98: 86-93 (2003)
85. Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP: Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis 46: 25-28 (2003)
86. VandenBergh MF, Verweij PE, Voss A: Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment. Diagn Microbiol Infect Dis 34: 221-227 (1999)
87. Vento S, Cainelli F: Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4: 595-604 (2003)
88. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT, Bacigalupo A: False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 38: 913-916 (2004)
89. Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie EJ: Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother 45: 3487-3496 (2001)
90. Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR: Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21: 240-248 (2002)
91. Warris A, Gaustad P, Meis JF, Voss A, Verweij PE, Abrahamsen TG: Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect 47: 143-148 (2001)
92. Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC: Intravenous, and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 138: 705-713 (2003)
93. Wright JA, Bradfield SM, Park JR, Hawkins DS: Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases. J Pediatr Hematol Oncol 25: 286-291 (2003)